Transfusion dose density affects myelodysplastic syndrome survival
(HealthDay)—Transfusion dose density is an independent prognostic factor for progression-free survival (PFS) in patients with myelodysplastic syndromes treated with red blood cell transfusions (RBCTs), according to a study ...
Jun 24, 2019
0
1